Business Name: |
Zebulon Kidney Center Southeast |
Contact Person: |
Bennet Claissa |
Address: |
835 South New Hope Road, Raleigh, North Carolina 27610 |
Phone Number: |
(919) 231-3700 |
Annual Revenue (USD): |
$100.000 to $499.999 |
Founding Year: |
2007 |
Location Type: |
Single Location |
Employee Number: |
1 to 4 |
Business Type: |
B2C (Business to Consumer) |
Business Category: |
Doctors |
SIC Code: |
8011 |
NAICS Code: |
621111 |
Share This Business: |
|
Related Businesses: |
Bleier Seth J MD - Raleigh, NC 27610 Schimizzi Aimee MD - Raleigh, NC 27610 Frisby Xenia MD - Raleigh, NC 27610 Zeok John V MD - Raleigh, NC 27610 Murphy Alison J MD - Raleigh, NC 27610 Gittelman David DO - Raleigh, NC 27610 Whitt Kerry N MD - Raleigh, NC 27610 Malhotra Amit MD - Raleigh, NC 27610 Kamil Alice L MD - Raleigh, NC 27610 Premakumar Sanjay K MD - Raleigh, NC 27610 Johnson Christopher MD - Raleigh, NC 27610 Messick Doreen MD - Raleigh, NC 27610 Subramaniam Geeta MD - Raleigh, NC 27610 Vanmatre Reed MD - Raleigh, NC 27610 Page Branson MD - Raleigh, NC 27610 Florea Sorin MD - Raleigh, NC 27610 Griffiths William O MD - Raleigh, NC 27610 Johnson Jana G MD - Raleigh, NC 27610 Park Robert S MD - Raleigh, NC 27610 Young Matthew M MD - Raleigh, NC 27610 |
The company Zebulon Kidney Center Southeast provides B2C services in the form of Doctors from its single location in North Carolina.
1 to 4 employees work for Zebulon Kidney Center Southeast, and the business now earns $100.000 to $499.999 per annum.
Zebulon Kidney Center Southeast was launched in 2007 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 .
To contact Zebulon Kidney Center Southeast, please call Bennet Claissa with the phone number (919) 231-3700 or visit its single location at 835 South New Hope Road in Raleigh, North Carolina 27610.
The location of the single location can also be found using the coordinates 35.763642,-78.559986.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.